Farmak JSC, the leader of the domestic pharmaceutical industry, has launched a website of its Representative Office in the Republic of Belarus, which can be found at farmak.by.
Farmak’s Representative Office in Belarus has been operating since April 2014. Although, it is worth mentioning that Farmak’s products have been launched in the market of Republic of Belarus long before opening the Representative Office.
The website of Representative Office features user-friendly Russian-language interface and clear structure, which makes it possible to find any required information with not more than three mouse clicks.
Maya Sandulska, Head of Department for Marketing of Export Markets, Farmak JSC, says, “The website of our Representative Office in the Republic of Belarus will allow deepening of our communications with the target audience in the local market. This will also enable us to provide, as promptly as possible, information about new medicinal products brought to the market of Belarus, social projects implemented by the Representative Office, operation of Representative Office and Farmak, available vacancies, and to obtain quick feedback from patients, potential partners, companies, and institutions interested in cooperation with the Representative Office”.
Farmak, as a member of the European Generic Medicines Association (EGA) – Medicines for Europe – and the Association of “Manufacturers of Drugs of Ukraine” (the AMDU), advocates for the creation of a coordination group at the Office of the President of Ukraine to prevent a shortage of medicines in Ukraine during the pandemic. […]
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]